Use of intrathecal SNX-111, a novel, N-type, voltage-sensitive, calcium channel blocker, in the management of intractable brachial plexus avulsion pain

Clinical Journal of Pain

Volumn 13, Issue 3, 1997, Pages 256-259

  Brose, William G ^a   Gutlove, David P ^a   Luther, Robert R ^b   Bowersox, S Scott ^b   McGuire, Dawn ^b,c,d  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b Neurex Corporation   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Dawn McGuire   (United States)

Author keywords

Allodynia; Analgesia; Brachial plexus avulsion; Calcium channel blocker; Deafferentation pain; Hyperesthesia; Neuropathic pain; SNX 111

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; OMEGA CONOTOXIN MVIIA;

ADULT; ALLODYNIA; ANALGESIC ACTIVITY; ARTICLE; AVULSION INJURY; BRACHIAL PLEXUS INJURY; CASE REPORT; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTINUOUS INFUSION; DEAFFERENTATION; GAZE PARALYSIS; HUMAN; HYPERESTHESIA; INDWELLING CATHETER; INTRACTABLE PAIN; INTRATHECAL DRUG ADMINISTRATION; MALE; NEUROPATHY; NYSTAGMUS; PAIN ASSESSMENT; PHANTOM PAIN; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; VERTIGO; VISUAL IMPAIRMENT;

ADULT; BRACHIAL PLEXUS; CALCIUM CHANNEL BLOCKERS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INJECTIONS, SPINAL; MALE; OMEGA-CONOTOXINS; PAIN MEASUREMENT; PAIN, INTRACTABLE; PEPTIDES; PHANTOM LIMB;

EID: 0030829127     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002508-199709000-00012     Document Type: Article

References (14)

1. Gracely RH, Lynch S, Bennett GJ. Painful neuropathy: altered central processing, maintained dynamically by peripheral input. Pain 1992;51:175-94.
2. Loeser JD, Ward AA. Some effects of deafferentation on neurons of the cat spinal cord. Arch Neurol 1967;17:629-36.
3. Nystrom B, Hagbarth KE. Microelectrode recordings from transected nerves in amputees with phantom limb pain. Neurosci Lett 1981;27:211-6.
4. Wynn Parry CB. Pain in avulsion lesions of the brachial plexus. Pain 1980;9:41-53.
5. Xie Y, Xiao W, Li H. The relationship between new ion channels and ectopic discharges from a region of nerve injury. Sci China B 1993;35:68-74.
6. Chaplan SR, Pogrel JW, Yaksh TL. Role of voltage-dependent calcium channel subtypes in experimental tactile allodynia. J Pharmacol Exp Ther 1994;269:1117-23.
7. Cruz LJ, Johnson DS, Olivera BM. Characterization of the ω-conotoxin target. Biochemistry 1987;26:820-4.
8. Kerr LM, Yoshikami D. A venom peptide with a novel presynaptic blocking action. Nature 1984;308:282-4.
9. Takemura M, Kyama H, Fukui H, Tohyama M, Wada H. Distribution of the ω-conotoxin receptor in rat brain: an autoradiographic mapping. Neuroscience 1989;32(2):405-16.
10. Malmberg AB, Yaksh TL. Effect of continuous intratheeal infusion of ω-conopeptides, N-type calcium-channel blockers, on behavior and antinuciception in the formalin and hot-plate tests in rats. Pain 1995;60:83-90.
11. Malmherg AB, Yaksh TL. Voltage-sensitive calcium channels in spinal nociceptive processing: blockade on N- and P-type channels inhibits formalin-induced nociception. J Neurosci 1994;14:4882-90.
12. Bowersox SS, Luther RR. SNX-111: N-type voltage-sensitive calcium channel antagonist. Drugs Future 1994;19(2): 128-30.
13. Neurex Scientific Report Nos. 5509-M009-94 and 54156 (unpublished data).
14. Brose WG, Pfeifer BL, Hassenbusch SJ, Burchiel KJ, Byas-Smith M, Krames E, McGuire D, Tich N, Luther RR. Analgesia produced by SNX-111 in patients with morphine-resistant pain. Abstract presented at 15th Annual Scientific Meeting American Pain Society, November 14-17, 1996.